Insider trades
Michael Cloonan, CEO of Sionna Therapeutics SION, has filed 0 purchases and 12 sales on the open market. Over the past 12 months that comes to a net sale of $4.4M. The latest trade was on 01/02.
Michael Cloonan
President & CEO
- Company
- Sionna Therapeutics SION
- First filing
- 24/06/24
- Trades
- 41 trades
- Buys / sales
- 0 / 12
- 12-month net buying
- −$4.4M
- Last trade
- 01/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
SION | Open-market sale10b5-1 plan | 25/10/21 | 25/10/22 | 99,800 sh4 trades | $36.26avg. | $3,618,560.35 | −15.4% |
SION | Open-market sale10b5-1 plan | 25/10/15–25/10/16 | 25/10/17 | 25,200 sh3 trades | $31.27avg. | $788,128.75 | −4.4% |
SION | Open-market sale10b5-1 plan | 25/09/26–25/09/29 | 25/09/30 | 25,000 sh2 trades | $29.11avg. | $727,874.05 | −4.4% |
SION | Open-market sale10b5-1 plan | 25/08/26–25/08/27 | 25/08/28 | 25,000 sh2 trades | $24.97avg. | $624,371.3 | −4.4% |
| Open-market sale10b5-1 plan | 25/08/20 | 25/08/21 | 25,000 sh | $22.75 | $568,750 | −4.4% |